fda warning bpc-157 unapproved drug safety concerns Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Taking unapproved drugs such as
Description
Physically, you might feel weak, dizzy, or notice a strange tingling or numbness in your hands and feet
Is AOD-9604 approved by the FDA
Timing considerations Most protocols recommend morning administration on an empty stomach
Why to avoid with MTHFR: Requires multiple conversion steps to become active MTHFR mutations impair these conversions Contains cyanide (though small amount) Least bioavailable form Found in most cheap multivitamins and fortified foods Bottom line: Choose methylcobalamin, hydroxocobalamin, or adenosylcobalamin instead
